Researchers at the University of Washington have found a drug to help people with spinal-cord injury (SCI) who have major depressive disorder (MDD).
MDD occurs in 25–30% of people with SCI, but there has been little to no research done to find an effective treatment. So, Charles Bombardier, PhD, and Jesse Fan, MD, held a study at the University of Washington to test the tolerability and effectiveness of venlafaxine hydrochloride extended-release in participants with SCI and MDD.
The study compared the before and after depression issues of 133 participants, some of whom took the venlafaxine and some of who took a placebo. Neither the participants nor the researchers knew who was taking which pill. At the end of the 12-week study, Bombardier and Fan found that most of the participants taking the venlafaxine tolerated the medication and experienced decreased symptoms of depression.
For more information, visit sci.washington.edu.
(Register or login to add comments.)